Orchard Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
N/A
Price/Sales ratio
N/A
Earnings per Share (EPS)
$-0.33

Historical Multiples (2016 – 2022)

2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-7.40-3.55-1.53-7.84-2.82-4.50-6.00-0.00-4.69
Price/Sales ratio
N/AN/A170.93510.16165.55338.786.770.02337.86
Price/Book Value ratio
-8.551.631.134.282.400.770.480.003.34
Price/Cash Flow ratio
-9.70-4.35-3.63-7.71-3.40-1.30-0.62-0.00-5.67
Price/Free Cash Flow ratio
-9.57-4.15-3.49-7.51-3.09-1.27-0.57-0.00-5.50
Price/Earnings Growth ratio
N/A-0.03-0.000.090.220.050.070.000.15
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A79.67%67.96%66.97%53.20%65.17%70.11%69.03%
Operating Profit Margin
N/AN/A-11321.33%-6879.14%-6049.24%-7539.33%-452.21%-561.44%-9100.24%
Pretax Profit Margin
N/AN/A-11056.11%-6592.20%-5884.77%-7499.79%-129.00%-675.49%-8824.15%
Net Profit Margin
N/AN/A-11102.84%-6503.06%-5856.60%-7525.67%-112.84%-665.01%-8802.95%
Effective Tax Rate
-0.10%-0.13%-0.42%1.35%0.47%-0.34%12.52%1.55%0.46%
Return on Assets
-445.59%-40.84%-62.96%-40.92%-54.09%-11.27%-3.60%-68.82%-47.51%
Return On Equity
115.49%-45.99%-74.03%-54.62%-85.17%-17.31%-8.02%-110.80%-69.89%
Return on Capital Employed
-4103.20%-44.50%-73.87%-50.33%-68.43%-13.02%-19.95%-80.33%-59.38%
Liquidity Ratios
Current Ratio
N/AN/A7.426.264.33N/AN/A2.775.29
Quick Ratio
1.048.767.426.264.326.382.722.655.29
Cash ratio
0.918.357.010.341.061.301.121.120.73
Days of Sales Outstanding
N/AN/A2.23K2.37K2.56K24.33K752.83279.322.47K
Days of Inventory outstanding
N/AN/AN/AN/A283.223.25K510.06183.28141.61
Operating Cycle
N/AN/A2.23K2.37K2.84K27.59K1.26K252.152.61K
Days of Payables Outstanding
N/AN/A15.67K5.43K3.75K16.16K1.39K502.294.59K
Cash Conversion Cycle
N/AN/A-13.43K-3.05K-911.5111.42K-134.98-177.78-8.24K
Debt Ratios
Debt Ratio
N/AN/AN/A0.110.200.180.260.550.33
Debt Equity Ratio
N/AN/AN/A0.150.320.280.591.220.69
Long-term Debt to Capitalization
N/AN/AN/A0.110.190.190.300.300.20
Total Debt to Capitalization
N/AN/AN/A0.130.240.220.370.370.25
Interest Coverage Ratio
N/AN/AN/A-112.40-67.43N/AN/A-41.31-76.85
Cash Flow to Debt Ratio
N/AN/AN/A-3.61-2.17-2.10-1.30-1.30-2.46
Company Equity Multiplier
-0.251.121.171.331.571.532.222.221.25
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-46.98-66.10-48.66-259-10.87-3.35-56.54
Free Cash Flow / Operating Cash Flow Ratio
1.011.041.041.021.101.021.081.081.03
Cash Flow Coverage Ratio
N/AN/AN/A-3.61-2.17-2.10-1.30-1.30-2.46
Short Term Coverage Ratio
N/AN/AN/A-28.19-9.15-15.40-4.79-4.79-16.49
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A